Ivan Schréter

2.5k total citations
23 papers, 153 citations indexed

About

Ivan Schréter is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Ivan Schréter has authored 23 papers receiving a total of 153 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 13 papers in Hepatology and 7 papers in Infectious Diseases. Recurrent topics in Ivan Schréter's work include Hepatitis B Virus Studies (11 papers), Hepatitis C virus research (9 papers) and Liver Disease Diagnosis and Treatment (7 papers). Ivan Schréter is often cited by papers focused on Hepatitis B Virus Studies (11 papers), Hepatitis C virus research (9 papers) and Liver Disease Diagnosis and Treatment (7 papers). Ivan Schréter collaborates with scholars based in Slovakia, Czechia and Germany. Ivan Schréter's co-authors include Pavol Kristián, Peter Jarčuška, Martin Janíčko, Pavol Jarčuška, Sylvia Dražilová, Erik Dorko, Kvetoslava Rimárová, Leonard Siegfried, Daniel Pella and Mária Mareková and has published in prestigious journals such as International Journal of Environmental Research and Public Health, Viruses and Vector-Borne and Zoonotic Diseases.

In The Last Decade

Ivan Schréter

21 papers receiving 144 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ivan Schréter Slovakia 9 75 64 47 32 25 23 153
Araceli Arce Arnáez Spain 8 126 1.7× 28 0.4× 59 1.3× 7 0.2× 11 0.4× 20 180
Abraham Assefa Ethiopia 8 128 1.7× 21 0.3× 116 2.5× 15 0.5× 8 0.3× 13 221
Emanoil Ceaușu Romania 10 123 1.6× 79 1.2× 109 2.3× 17 0.5× 4 0.2× 45 243
Audrey Gabassi France 8 61 0.8× 39 0.6× 113 2.4× 6 0.2× 17 0.7× 24 173
Jamie A. Murkey United States 4 73 1.0× 17 0.3× 50 1.1× 7 0.2× 5 0.2× 6 145
Susan V. Lipton United States 6 97 1.3× 9 0.1× 23 0.5× 17 0.5× 6 0.2× 10 139
Ryan Thompson United States 8 127 1.7× 5 0.1× 63 1.3× 20 0.6× 18 0.7× 13 208
Marie Downer United States 5 54 0.7× 11 0.2× 72 1.5× 3 0.1× 10 0.4× 6 122
Mar Lago Spain 7 43 0.6× 22 0.3× 132 2.8× 27 0.8× 3 0.1× 13 173
K. K. Kyuregyan Russia 8 128 1.7× 155 2.4× 95 2.0× 8 0.3× 2 0.1× 66 213

Countries citing papers authored by Ivan Schréter

Since Specialization
Citations

This map shows the geographic impact of Ivan Schréter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Schréter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Schréter more than expected).

Fields of papers citing papers by Ivan Schréter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan Schréter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Schréter. The network helps show where Ivan Schréter may publish in the future.

Co-authorship network of co-authors of Ivan Schréter

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan Schréter. A scholar is included among the top collaborators of Ivan Schréter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan Schréter. Ivan Schréter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kristián, Pavol, Marek Rác, Sylvia Dražilová, et al.. (2023). Is Slovakia Almost a Hepatitis D Free Country?. Viruses. 15(8). 1695–1695.
2.
Janíčko, Martin, et al.. (2023). Importance of CHB‘s grey zone: analysis of patients with HBeAg negative chronic hepatitis B virus infection. Bratislavské lekárske listy/Bratislava medical journal. 125(1). 59–63. 1 indexed citations
3.
Kristián, Pavol, et al.. (2019). Noninvasive Assessment of Liver Fibrosis in Patients with Chronic Hepatitis B or C by Contrast-Enhanced Magnetic Resonance Imaging. Canadian Journal of Gastroenterology and Hepatology. 2019. 1–8. 10 indexed citations
4.
Dorko, Erik, et al.. (2018). Milk outbreaks of tick-borne encephalitis in Slovakia, 2012-2016. Central European Journal of Public Health. 26(Supplement). S47–S50. 29 indexed citations
5.
Novotný, Martin, et al.. (2018). Single centre clinical experience with fidaxomicin in the treatment of Clostridium difficile infection in Slovakia. Central European Journal of Public Health. 26(Supplement). S76–S80. 1 indexed citations
6.
Dražilová, Sylvia, Martin Janíčko, Pavol Kristián, et al.. (2018). Prevalence and Risk Factors for Hepatitis B Virus Infection in Roma and Non-Roma People in Slovakia. International Journal of Environmental Research and Public Health. 15(5). 1047–1047. 17 indexed citations
7.
Dražilová, Sylvia, Martin Janíčko, Ľubomír Skladaný, et al.. (2018). Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals. Canadian Journal of Gastroenterology and Hepatology. 2018. 1–10. 19 indexed citations
8.
Dražilová, Sylvia, et al.. (2015). Lower Viral Response to Pegylated Interferon Alpha 2a Treatment of Chronic Hepatitis B in Roma People in Eastern Slovakia. Gastroenterology Research and Practice. 2016. 1–6. 4 indexed citations
9.
Veselíny, Eduard, Martin Janíčko, Sylvia Dražilová, et al.. (2014). High Hepatitis B and Low Hepatitis C Prevalence in Roma Population in Eastern Slovakia. Central European Journal of Public Health. 22(Supplement). S51–S56. 11 indexed citations
10.
Kristián, Pavol, et al.. (2013). Regional and Ethnic Aspects of Viral Hepatitis B among Pregnant Women. Central European Journal of Public Health. 21(1). 22–25. 8 indexed citations
11.
Habalová, Viera, Lucia Klimčáková, Jozef Židzik, et al.. (2012). Closed tube method for rapid screening of IL28B polymorphisms involved in response to hepatitis C treatment. Molecular and Cellular Probes. 26(4). 159–163. 1 indexed citations
12.
Kristián, Pavol, et al.. (2010). Impact of TTV and SENV infection in chronic hepatitis B or C on liver histology and therapy outcome.. PubMed. 111(12). 629–34. 2 indexed citations
13.
Schréter, Ivan, et al.. (2009). Outbreak of trichinellosis in eastern Slovakia. Helminthologia. 46(4). 209–213. 8 indexed citations
14.
Schréter, Ivan, et al.. (2008). [Haematologic adverse effects of treatment of chronic viral hepatitis B and C].. PubMed. 14(2). 74–8. 2 indexed citations
15.
Fingerle, Volker, A. Štefančíková, Ulrike Schulte-Spechtel, et al.. (2008). Evaluation of Recombinant Line Immunoblot for Detection of Lyme Disease in Slovakia: Comparison with Two Other Immunoassays. Vector-Borne and Zoonotic Diseases. 8(3). 381–390. 5 indexed citations
16.
Schréter, Ivan, et al.. (2007). [Prevalence of hepatitis C virus infection in Slovakia].. PubMed. 13(2). 54–8. 10 indexed citations
17.
Kristián, Pavol, et al.. (2006). Prevalence, Epidemiological Aspects and Clinical Importance of TT Virus Infection in Slovakia. Acta Medica (Hradec Kralove Czech Republic). 49(1). 41–45. 1 indexed citations
18.
Schréter, Ivan, et al.. (2006). Detection of SEN virus in the general population and different risk groups in Slovakia. Folia Microbiologica. 51(3). 223–8. 8 indexed citations
19.
Schréter, Ivan, et al.. (1993). [Occurrence of acute infectious diarrhea during the lunar phases].. PubMed. 132(16). 498–501. 8 indexed citations
20.
Greśíková, M, et al.. (1989). [The incidence and clinical picture of hemorrhagic fever with renal syndrome in East Slovakia: the eastern and western type].. PubMed. 90(11). 852–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026